Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,498,000 | 6,057,000 | 6,229,000 | 6,574,000 | 6,964,000 |
| Marketable Securities | 170,000 | 277,000 | 431,000 | 359,000 | 341,000 |
| Inventories | 4,035,000 | 3,837,000 | 4,074,000 | 4,070,000 | 4,157,000 |
| Other current assets | 6,098,000 | 5,865,000 | 6,059,000 | 6,076,000 | 6,894,000 |
| TOTAL | $16,801,000 | $16,036,000 | $16,793,000 | $17,079,000 | $18,356,000 |
| Non-Current Assets | |||||
| PPE Net | 9,020,000 | 9,045,000 | 9,152,000 | 9,180,000 | 9,532,000 |
| Intangibles | 12,292,000 | 12,138,000 | 11,853,000 | 11,923,000 | 11,936,000 |
| Other Non-Current Assets | 4,465,000 | 5,011,000 | 4,850,000 | 4,871,000 | 4,733,000 |
| TOTAL | $25,777,000 | $26,194,000 | $25,855,000 | $25,974,000 | $26,201,000 |
| Total Assets | $42,578,000 | $42,230,000 | $42,648,000 | $43,053,000 | $44,557,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 258,000 | 291,000 | 386,000 | 453,000 | 1,034,000 |
| Accounts payable and accrued liabilities | 7,246,000 | 6,888,000 | 6,806,000 | 6,568,000 | 6,796,000 |
| Other current liabilities | N/A | 188,000 | 231,000 | 209,000 | 127,000 |
| TOTAL | $13,111,000 | $12,794,000 | $11,243,000 | $12,002,000 | $12,153,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,829,000 | 14,809,000 | 14,851,000 | 14,848,000 | 15,220,000 |
| Other Non-Current Liabilities | 3,203,000 | 3,317,000 | 4,431,000 | 5,216,000 | 4,335,000 |
| TOTAL | $19,580,000 | $19,691,000 | $20,792,000 | $21,507,000 | $20,978,000 |
| Total Liabilities | $32,691,000 | $32,485,000 | $32,035,000 | $33,509,000 | $33,131,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,416,000 | 1,418,000 | 1,417,000 | 1,417,000 | 1,417,000 |
| Retained earnings | 4,985,000 | 4,779,000 | 5,839,000 | 4,914,000 | 6,822,000 |
| Other shareholders' equity | 1,235,000 | 1,262,000 | 1,153,000 | 1,050,000 | 1,047,000 |
| TOTAL | $9,071,000 | $8,887,000 | $9,809,000 | $8,769,000 | $10,670,000 |
| Total Liabilities And Equity | $41,762,000 | $41,372,000 | $41,844,000 | $42,278,000 | $43,801,000 |